Moreover, PLS-DA (Fig. 1A–C and supplementary Table S1), an supervised analysis method, also allowed for the detection of differences between individuals with and without NAFLD independent of their ALT level, indicating distinctive fecal microbial communities between HC and NAFLD groups. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.